Immunosuppressive arenaviral exoribonuclease
نویسندگان
چکیده
منابع مشابه
Arenaviral vaccine vectors to combat infectious diseases
In recent years, the use of viral vaccine vectors has gained immense interest over traditional vaccine strategies due to their ability to replicate in order to induce high immune responses against the intended antigens without the need for adjuvant co-administration. Several viral vectors, including but not necessarily limited to adenoviruses, poxviruses and alphaviruses are currently in variou...
متن کاملVaccine Platforms to Control Arenaviral Hemorrhagic Fevers.
Arenaviruses are rodent-borne emerging human pathogens. Diseases caused by these viruses, e.g., Lassa fever (LF) in West Africa and South American hemorrhagic fevers (HFs), are serious public health problems in endemic areas. We have employed replication-competent and replication-deficient strategies to design vaccine candidates potentially targeting different groups "at risk". Our leader LF va...
متن کاملTargeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination.
Members of the arenavirus family, famous for their hemorrhagic syndromes, cause distinct neurological disorders; however, cellular and molecular targets as well as pathogenesis of peripheral nervous system disorders associated with these viruses are unknown. Using noncytolytic lymphocytic choriomeningitis virus, the prototype arenavirus, and pseudotyped Lassa fever virus, we showed that the Sch...
متن کاملUniquely conserved immunosuppressive viral exoribonucleases
The interplay between viruses and host immune responses is critical to determine either a successful infection or resolution. Mammalian cells have developed different mechanisms to recognize invading pathogens via their pathogen-associated molecular patterns (PAMPs), which are often nucleic acid products (e.g., doublestranded RNAs or dsRNA) generated during viral genome replication [1]. To evad...
متن کاملImmunosuppressive Medications.
Immunosuppressive agents are commonly used in the nephrologist's practice in the treatment of autoimmune and immune-mediated diseases and transplantation, and they are investigational in the treatment of AKI and ESRD. Drug development has been rapid over the past decades as mechanisms of the immune response have been better defined both by serendipity (the discovery of agents with immunosuppres...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncotarget
سال: 2015
ISSN: 1949-2553
DOI: 10.18632/oncotarget.6110